Pharmafile Logo
Pharmafocus logo
Advanced Search

pascal soriot

Showing 3 posts of 3 posts found.

cq5dam

AstraZeneca spends more than twice as much as expected on new HQ

June 12, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cambridge, UK, headquarters, pascal soriot, pharma

AstraZeneca’s new headquarters in Cambridge, United Kingdom are expected to cost more than double the sum of £330 million that …

News
pascal_soriot

AstraZeneca’s CEO set for shock switch to Teva

July 13, 2017
Medical Communications AstraZeneca, Teva, biotech, drugs, pascal soriot, pharma, pharmaceutical

It is no secret that Teva has been on the lookout for a new CEO and they had already been …

News
abpi_reception_right

UK pharma would benefit by remaining in EU, says ABPI

May 9, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Andrew Witty, EU, brexit, letter, observer, pascal soriot, remain, stay

With the EU vote approaching, the Association of the British Pharmaceutical Industry (ABPI) has brought together 93 signatories, including the …

News

Latest content

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024

Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder

April 22, 2024

Ardena announces €20m expansion following first GMP approval

April 19, 2024